Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.0;REH: 11.6;RPMI-8226: 14.2;U-698: 21.0;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 47.8;naive B-cell: 33.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005093, HPA069571"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB005093: AB_2274756, HPA069571: "	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.3	2.4	0.0	0.1	0.1	23.5	0.0	0.1	31.9	1.4	0.2	0.0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0.0	0.0	9.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.6	0.0	14.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	3.7	21.0	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.8	47.8	0.3	1.1	0.0	33.9	0.2	0.1	0.1	0.0	0.0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609533-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"blood: 75.5;lymphoid tissue: 59.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;Karpas-707: 8.0;REH: 5.2;U-698: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	16	"memory B-cell: 34.3;naive B-cell: 75.5"	"Lineage enriched"	"Detected in many"	22	"B-cells: 75.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 3.6"	"Low region specificity"	"Detected in all"			"CAB002505, HPA044658"	Enhanced		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: "	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (2.49e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.59e-2)"	1.9	1.2	0.8	16.6	1.1	2.6	1.3	0.6	0.6	0.7	0.9	0.2	0.5	0.3	0.8	2.1	0.8	0.7	1.6	0.6	0.8	0.7	1.5	2.3	2.2	26.8	0.8	0.1	0.5	1.4	0.5	1.6	1.5	1.1	0.9	0.3	1.1	3.4	0.1	0.5	0.8	5.2	0.6	1.8	59.7	0.8	0.8	0.2	1.5	1.4	0.3	22.2	4.9	0.6	75.5	3.4	0.2	0.6	1.7	0.7	2.5	0.1	0.0	0.4	0.2	0.7	3.8	0.1	0.2	0.1	0.3	0.5	0.0	0.1	12.4	0.0	0.2	0.0	0.0	0.1	0.4	1.2	0.3	0.4	0.0	0.0	0.4	0.2	2.8	1.1	0.0	0.2	0.3	0.0	0.0	8.0	0.7	0.0	0.2	1.6	0.1	0.1	5.2	0.0	3.8	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.1	0.2	27.7	0.5	0.4	0.0	0.0	0.3	0.0	0.5	0.6	0.7	34.3	0.2	0.3	3.4	75.5	0.1	0.4	0.2	1.7	0.0	1.8	0.3	2.5	0.8	1.1	0.6	0.6	0.8	0.7	0.8	0.1	1.1	0.2
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	5	"HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	55.5	0.0	30.5	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3
FCER2	"CD23, CD23A, CLEC4J, FCE2"	ENSG00000104921	"Fc fragment of IgE receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 87.2;lymphoid tissue: 38.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 97.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"memory B-cell: 28.2;naive B-cell: 87.2"	"Lineage enriched"	"Detected in many"	34	"B-cells: 87.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002624, HPA008928"	Enhanced				"Secreted to blood"	59000	59000			"CAB002624: , HPA008928: AB_1846285"	"unprognostic (3.20e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.46e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.17e-2)"	2.4	0.3	0.5	17.1	0.5	2.3	1.2	0.3	1.1	0.3	1.0	0.1	0.4	1.3	0.3	2.3	1.0	0.4	0.5	0.8	0.3	0.3	0.6	0.6	0.8	21.1	0.3	0.0	0.4	0.3	0.0	0.3	0.3	0.1	0.3	0.8	0.0	7.5	0.7	0.4	0.6	7.7	0.4	0.3	38.4	0.8	0.5	0.0	6.3	0.7	0.0	33.8	2.0	0.5	87.2	0.7	0.2	2.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	97.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.5	0.0	0.0	2.5	0.0	28.2	0.0	0.0	0.7	87.2	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.0	0.5	0.5	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 20.2;intestine: 14.9;lymphoid tissue: 27.0"	"Group enriched"	"Detected in some"	4	"Daudi: 14.7;U-698: 11.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	50	"memory B-cell: 20.2;naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	65	"B-cells: 20.2"																				"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"	0.4	0.2	0.2	22.6	0.2	1.5	0.2	0.1	0.2	0.2	1.3	0.1	0.1	1.2	0.3	0.1	1.4	0.2	0.4	0.2	0.2	0.2	0.5	0.9	0.7	15.6	0.3	0.1	0.5	0.2	0.0	0.2	0.1	0.2	0.4	1.7	0.6	2.8	0.7	0.1	0.2	14.9	0.1	0.2	27.0	0.8	0.2	0.1	0.3	0.5	0.1	23.3	1.4	0.2	20.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.1	0.0	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.2	0.1
CD79A	"IGA, MB-1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877120-41881372	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 125.3;intestine: 43.5;lymphoid tissue: 119.2"	"Group enriched"	"Detected in some"	24	"Daudi: 155.5;REH: 48.3;U-698: 135.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 106.4;naive B-cell: 125.3"	"Lineage enriched"	"Detected in many"	41	"B-cells: 125.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB000019	Enhanced									"CAB000019: AB_2244527"	"prognostic favourable (8.45e-5)"	"unprognostic (1.63e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.23e-2)"	"unprognostic (8.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (6.08e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	1.3	0.6	0.5	103.8	0.5	5.4	1.3	0.5	0.5	1.8	6.3	0.1	0.1	4.9	0.6	0.2	4.4	1.0	2.3	0.8	0.5	0.5	2.3	0.9	4.3	114.9	0.5	0.1	0.6	0.6	0.0	0.5	0.5	0.1	1.0	3.4	1.8	13.6	1.2	0.5	0.5	43.5	0.2	0.5	108.1	9.7	0.8	0.1	32.0	2.4	1.9	119.2	6.8	1.0	125.3	3.0	0.7	0.3	0.2	2.3	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	0.0	0.0	48.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.7	0.1	135.4	0.0	4.6	0.0	0.7	0.1	0.5	0.1	0.1	0.0	106.4	0.3	0.1	0.2	125.3	0.4	2.3	0.4	0.2	0.3	3.0	0.8	4.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.1	0.1
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754468	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9"	"Group enriched"	"Detected in some"	45	"Daudi: 56.9;REH: 67.3;U-698: 17.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	730	"memory B-cell: 79.9;naive B-cell: 90.4"	"Lineage enriched"	"Detected in single"	775	"B-cells: 90.4"	"Not detected"	"Not detected"							HPA003041	Supported				"Intracellular and membrane"					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	0.5	9.2	0.7	62.6	0.9	7.5	0.3	0.7	0.8	0.3	1.3	0.3	0.2	0.2	0.3	27.9	2.3	0.1	0.7	0.4	0.6	0.7	1.1	0.9	1.2	77.9	0.8	0.2	0.3	0.3	0.1	1.4	0.3	0.2	0.6	0.9	0.4	4.8	0.2	0.8	0.4	32.7	0.2	0.5	31.6	1.4	1.4	0.2	1.6	0.8	1.0	36.0	3.1	0.2	90.4	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.2	67.3	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.3	0.0	17.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.9	0.0	0.0	0.0	90.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.7	0.9	0.7	0.8	0.6	0.7	0.8	0.2	0.2	0.2
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931939-28939346	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 47.6;intestine: 16.7;lymphoid tissue: 40.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 52.1;REH: 27.6;U-698: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"memory B-cell: 36.0;naive B-cell: 47.6"	"Lineage enriched"	"Detected in single"	106	"B-cells: 47.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB016110	Enhanced									"CAB016110: AB_626952"	"unprognostic (3.27e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.11e-5)"	"unprognostic (2.61e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-1)"	0.4	0.2	0.2	37.0	0.2	2.3	0.2	0.1	0.2	0.2	0.9	0.1	0.0	0.2	0.2	0.1	1.4	0.3	0.2	0.2	0.2	0.2	0.7	0.3	1.4	32.0	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.4	0.5	0.1	5.9	0.0	0.1	0.1	16.7	0.0	0.2	40.3	1.3	1.9	0.0	2.4	0.7	0.2	38.7	1.8	0.3	47.6	0.0	0.4	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	47.6	0.1	0.0	0.3	0.0	0.1	0.0	0.0	1.8	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455752-60470760	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1"	"Group enriched"	"Detected in some"	25	"Daudi: 120.0;U-698: 60.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"memory B-cell: 77.7;naive B-cell: 77.7"	"Lineage enriched"	"Detected in single"	105	"B-cells: 77.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favourable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	1.6	0.3	0.3	79.0	0.3	3.6	0.6	0.3	0.3	0.5	2.0	0.0	0.0	0.2	0.4	0.5	7.0	0.4	1.3	0.7	0.3	0.3	2.0	0.9	2.7	81.2	0.3	0.1	0.3	0.4	0.0	0.4	0.4	0.1	1.1	1.7	0.6	14.5	0.2	0.3	0.3	46.1	0.1	0.4	90.7	2.6	0.6	0.0	15.7	2.5	2.7	134.1	6.4	0.8	77.7	0.0	0.2	0.0	0.7	0.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	77.7	0.3	0.6	0.0	77.7	0.0	0.2	0.2	0.7	0.0	0.0	0.0	3.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.0
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.2	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.5	10.2	1.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.0	2.1	0.0	0.1	7.1	0.0	0.5	0.3	0.0	0.0	0.1	0.0	3.1	0.4	0.4	0.0	0.4	0.0	4.3	0.1	0.4	0.0	0.3	4.7	2.0	0.0	0.2	0.1	0.0	0.4	1.8	1.0	0.0	0.4	0.0	0.0	24.5	0.0	1.6	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 97.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.1;MOLT-4: 11.5;RPMI-8226: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 13.3;naive B-cell: 16.2"	"Lineage enriched"	"Detected in many"	9	"B-cells: 16.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB002659, HPA052942, HPA060715"	Enhanced					150000000	150000000			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favourable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	0.5	0.3	0.4	97.2	0.3	0.0	0.4	0.3	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	2.8	0.3	0.3	0.3	0.4	0.4	1.4	0.4	2.0	72.8	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.0	6.0	0.0	0.4	0.3	11.5	0.0	0.4	63.4	1.4	0.5	0.0	6.5	0.7	0.3	56.3	0.6	0.3	16.2	0.0	0.2	0.0	0.0	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.5	0.0	1.9	0.2	0.0	0.2	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	13.3	0.7	0.5	0.0	16.2	1.8	1.6	0.2	0.0	0.0	0.0	0.0	1.1	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.0	0.0
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463968-112499561	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.2;lymphoid tissue: 30.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 2.4;Daudi: 1.9;U-698: 6.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 22.6;naive B-cell: 37.2"	"Lineage enriched"	"Detected in many"	4	"B-cells: 37.2"	"Not detected"	"Not detected"							"HPA047211, HPA062029"	Enhanced									"HPA047211: AB_2679983, HPA062029: AB_2684665"	"unprognostic (1.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (5.79e-4)"	"unprognostic (1.01e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.74e-6)"	"unprognostic (6.20e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.53e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.57e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.42e-2)"	0.6	0.3	0.3	20.3	0.4	1.2	1.1	0.4	0.3	0.5	1.2	0.1	0.0	0.9	0.4	0.1	2.3	0.5	1.0	0.4	0.3	0.3	1.0	0.5	1.2	30.9	0.3	0.0	0.4	0.3	0.0	0.4	0.3	0.1	0.5	0.9	0.2	5.7	0.4	0.3	0.5	6.0	0.2	0.4	18.6	1.7	0.6	0.0	14.6	0.9	1.1	19.4	2.8	0.5	37.2	8.6	0.1	0.0	0.1	5.1	2.4	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.9	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.1	22.6	5.1	2.4	1.5	37.2	4.8	4.7	0.1	0.1	0.0	8.6	1.1	2.4	0.3	0.4	0.4	0.3	0.3	0.3	0.3	0.0	0.1	0.0
OR4C6		ENSG00000181903	"Olfactory receptor family 4 subfamily C member 6"	Q8NH72	11	55662201-55666195	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 1.8;lymphoid tissue: 1.7"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 7.9;Karpas-707: 8.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.8"																																					0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3			0.0		1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLEC17A	FLJ45910	ENSG00000187912	"C-type lectin domain containing 17A"	Q6ZS10	19	14583084-14611157	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 30.9;intestine: 8.5;lymphoid tissue: 25.1"	"Group enriched"	"Detected in some"	10	"Daudi: 9.9;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"memory B-cell: 14.7;naive B-cell: 30.9"	"Lineage enriched"	"Detected in many"	16	"B-cells: 30.9"					"Low region specificity"	"Detected in all"														"unprognostic (4.71e-5)"	"unprognostic (1.34e-2)"	"unprognostic (9.64e-4)"	"unprognostic (5.02e-3)"	"unprognostic (3.90e-1)"	"unprognostic (9.00e-4)"	"unprognostic (3.18e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	0.4	0.3	0.8	23.2	2.2	1.3	0.3	0.3	1.3	0.3	0.6	3.3	0.0	0.4	0.3	0.0	0.4	0.3	0.6	0.3	2.2	1.1	0.6	0.3	0.4	18.7	1.3	0.0	0.3	0.3	0.1	0.5	0.1	1.7	0.4	0.6	0.4	4.7	0.0	0.3	0.3	8.5	0.0	3.7	17.0	0.7	1.4	2.0	1.0	0.5	0.0	25.1	1.5	0.3	30.9	1.8	0.7	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	14.7	0.0	0.0	1.8	30.9	0.0	0.0	0.7	0.1	0.1	0.2	0.0	1.3	0.8	2.2	0.3	1.3	2.2	1.1	1.3	0.0	1.7	2.0
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883766-118897799	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 35.5;lymphoid tissue: 45.6"	"Group enriched"	"Detected in some"	10	"Daudi: 10.3;U-698: 36.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 4.0"	"Group enriched"	"Detected in some"	8	"memory B-cell: 24.2;naive B-cell: 35.5"	"Lineage enriched"	"Detected in many"	9	"B-cells: 35.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB026149, HPA042432"	Enhanced									"CAB026149: , HPA042432: "	"unprognostic (8.51e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-1)"		"unprognostic (4.02e-5)"		"unprognostic (2.08e-2)"	"unprognostic (3.23e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-5)"	"unprognostic (4.21e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	0.4	0.8	0.6	31.8	0.6	7.3	0.1	4.0	0.9	0.1	3.6	0.2	0.1	0.1	0.2	0.1	2.6	0.0	0.5	0.9	0.7	0.5	0.8	1.0	0.9	31.5	0.3	0.1	0.3	0.5	0.0	0.9	0.1	0.2	2.9	0.3	0.3	3.6	0.1	1.3	0.9	8.6	0.1	0.3	45.6	1.3	0.1	0.1	1.9	0.7	1.3	41.8	3.9	0.9	35.5	0.0	0.0	0.0	0.0	3.9	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	10.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.5	0.0	0.2	0.4	0.0	0.0	0.2	0.0	36.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.3	24.2	3.9	1.0	0.0	35.5	0.4	0.3	0.0	0.0	0.0	0.0	0.5	1.9	0.6	0.6	4.0	0.9	0.7	0.5	0.3	0.1	0.2	0.1
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2 "	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9"	"Cell line enriched"	"Detected in some"	8	"REH: 54.7"									"Group enriched"	"Detected in some"	363	"memory B-cell: 75.1;naive B-cell: 42.7"	"Lineage enriched"	"Detected in single"	463	"B-cells: 75.1"														"Secreted to blood"																							0.8	0.0		14.4		2.6	2.8		0.0	10.9	32.1			24.1	0.0	0.0	4.3	0.0	1.0	0.0			0.0	0.0	0.7	5.5			0.0	0.0	0.0		0.0		0.0	11.1		11.1	0.0	0.0	0.0	6.4	0.6		9.4	11.7	0.0			0.0		37.1	45.9		75.1	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.1	0.1	0.0	54.7	0.6	1.2	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0										
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820105	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 31.6;lymphoid tissue: 55.1"	"Group enriched"	"Detected in some"	33	"Daudi: 5.6;U-698: 18.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"memory B-cell: 16.8;naive B-cell: 31.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 31.6"					"Low region specificity"	"Detected in all"			HPA013323	Enhanced					120000	120000			"HPA013323: AB_1848480"	"unprognostic (6.52e-4)"	"unprognostic (3.49e-3)"	"unprognostic (8.68e-3)"	"unprognostic (8.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-5)"	"unprognostic (1.47e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.74e-2)"	0.5	0.2	0.2	55.1	0.2	6.2	0.3	0.2	0.2	0.2	0.7	0.0	0.0	0.0	0.2	0.1	2.4	0.3	0.2	0.3	0.2	0.2	0.7	0.5	1.9	19.2	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.5	0.3	0.3	5.4	0.7	0.2	0.2	10.1	0.0	0.2	25.3	0.4	0.2	0.0	1.1	0.7	0.4	49.0	4.5	0.8	31.6	0.0	0.4	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.8	0.0	0.0	0.0	31.6	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol		"HPA021948: AB_1854878, HPA067827: "	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573749-157598080	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 5.4;lymphoid tissue: 15.6"	"Cell line enriched"	"Detected in single"	102	"U-266/70: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"					"Low region specificity"	"Detected in many"			HPA054030	Approved									"HPA054030: "	"unprognostic (6.06e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.08e-2)"		"unprognostic (4.69e-4)"		"unprognostic (2.06e-2)"			"unprognostic (6.38e-2)"			"unprognostic (1.99e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-1)"	"unprognostic (6.77e-2)"	0.1	0.1	0.1	15.6	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	2.5	0.0	0.1	0.1	5.4	0.0	0.1	2.2	0.3	0.1	0.0	1.1	0.1	1.9	14.9	0.4	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
FCRLA	"FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595"	ENSG00000132185	"Fc receptor like A"	Q7L513	1	161706972-161714352	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 66.3;lymphoid tissue: 51.8"	"Group enriched"	"Detected in some"	6	"Daudi: 91.8;SK-MEL-30: 37.8;U-698: 50.9"	"Cancer enriched"	"Detected in many"	21	"melanoma: 38.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 66.3;naive B-cell: 61.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016545	Enhanced				"Intracellular and membrane"					"CAB016545: AB_2247037"	"unprognostic (5.46e-4)"	"unprognostic (7.19e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.75e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.48e-4)"	"unprognostic (1.45e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.66e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.84e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-2)"	0.4	0.2	0.6	31.7	0.7	1.3	0.3	0.2	0.3	0.2	0.9	0.2	0.0	0.2	0.2	0.0	2.4	0.2	0.2	0.6	0.5	0.3	0.6	0.4	0.4	26.3	0.4	0.0	0.2	0.2	0.0	0.2	0.1	0.2	0.5	0.9	0.6	4.8	0.0	0.4	0.6	13.9	0.0	0.7	42.4	1.3	0.2	0.1	2.0	0.5	0.3	51.8	1.9	0.4	66.3	6.9	0.0	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.1	0.0	0.0	91.8	0.0	1.3	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	10.6	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	50.9	0.5	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	66.3	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	6.9	0.0	2.7	0.6	0.7	0.2	0.3	0.5	0.3	0.4	0.0	0.2	0.1
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932354	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 138.8;lymphoid tissue: 56.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 114.9;REH: 37.8;U-698: 157.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 100.6;naive B-cell: 138.8"	"Lineage enriched"	"Detected in many"	6	"B-cells: 138.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751"	Enhanced									"CAB009751: AB_2275844, HPA009178: AB_1078483"	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	1.7	0.7	0.4	50.6	0.4	11.1	1.2	0.3	0.4	0.6	1.7	0.3	0.3	0.7	0.6	0.5	2.6	0.6	1.4	3.4	0.4	0.2	2.3	1.7	1.3	56.6	0.4	0.3	0.6	1.6	0.0	9.0	0.5	0.3	1.0	1.3	0.8	8.9	0.9	1.2	0.9	22.4	0.5	0.4	56.0	1.8	0.6	0.3	3.7	1.4	1.7	46.6	4.5	0.9	138.8	4.2	0.5	25.0	3.4	9.2	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.3	0.0	0.0	0.0	2.4	0.0	0.0	37.8	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.0	0.4	0.0	0.0	5.8	5.6	157.4	0.0	0.2	0.0	0.5	1.1	0.0	4.2	16.5	4.8	100.6	5.4	2.8	4.2	138.8	3.7	2.2	0.5	3.4	25.0	0.6	9.2	9.0	0.4	0.4	0.3	0.4	0.4	0.2	0.4	0.3	0.3	0.3
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896107	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 87.9;lymphoid tissue: 102.9"	"Group enriched"	"Detected in some"	7	"Daudi: 101.1;U-266/70: 72.4;U-698: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	230	"memory B-cell: 87.9;naive B-cell: 72.8"	"Lineage enriched"	"Detected in single"	252	"B-cells: 87.9"														"Secreted to blood"	120000000000	120000000000				"prognostic favourable (6.10e-4)"	"unprognostic (7.64e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.82e-2)"	"prognostic favourable (3.41e-5)"	"unprognostic (1.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (5.94e-8)"	"unprognostic (1.85e-1)"	"unprognostic (4.63e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.50e-2)"	3.5	1.8	1.3	82.6	1.5	6.5	12.3	1.3	1.5	3.3	37.7	1.4	1.3	39.0	1.5	1.7	7.5	4.3	5.8	1.3	1.3	0.3	4.6	3.6	10.8	22.8	1.5	1.3	2.1	1.3	0.0	1.3	1.5	1.7	2.1	23.3	3.3	42.9	2.8	1.5	0.6	25.2	1.3	1.3	102.9	27.7	3.1	1.3	5.8	5.8	2.9	69.8	38.2	2.6	87.9	0.3	0.1	0.0	0.0	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	101.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	72.4	11.7	68.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.1	72.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	10.7	1.3	1.5	1.3	1.5	1.3	0.3	1.5	1.3	1.7	1.3
PAX5	BSAP	ENSG00000196092	"Paired box 5"	Q02548	9	36833275-37034185	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 21.6;lymphoid tissue: 33.4"	"Group enriched"	"Detected in some"	8	"Daudi: 21.0;REH: 61.0;U-698: 27.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 1.6"	"Group enriched"	"Detected in some"	209	"memory B-cell: 20.1;naive B-cell: 21.6"	"Lineage enriched"	"Detected in single"	216	"B-cells: 21.6"	"Region enriched"	"Detected in single"	11	"midbrain: 4.7"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 3.8;midbrain: 10.8;pons and medulla: 3.2"	"CAB026269, CAB026869, HPA056394, HPA068498"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB026269: , CAB026869: , HPA056394: AB_2683116, HPA068498: "	"unprognostic (4.69e-4)"	"unprognostic (3.83e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.15e-1)"	"unprognostic (8.96e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.01e-1)"	0.4	0.2	0.2	33.4	0.2	5.5	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.4	0.2	0.2	0.3	0.5	0.3	0.3	23.2	1.6	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.3	0.3	0.4	2.5	0.0	0.6	0.2	8.7	0.0	0.3	16.5	0.7	0.9	0.0	2.3	0.4	0.2	30.1	1.3	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.1	61.0	0.1	0.1	0.0	0.0	4.3	1.0	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	1.6	0.0	0.2	0.0
AC233755.2		ENSG00000277856			Unmapped	26241-26534	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 20.4;intestine: 14.5;lymphoid tissue: 33.2;stomach 1: 13.5"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 11.9;REH: 3.7;RH-30: 1.9;SH-SY5Y: 4.0;TIME: 2.6"									"Group enriched"	"Detected in some"	180	"memory B-cell: 15.5;naive B-cell: 20.4"	"Lineage enriched"	"Detected in single"	205	"B-cells: 20.4"																																					0.3	0.0		4.2		2.9	1.1		0.0	0.7	14.5			14.1	0.0	0.0	1.9	0.0	0.0	0.0			0.0	0.0	0.0	11.8			0.0	0.0	0.0		0.0		0.0	2.4		5.5	0.0	0.0	0.0	4.2	0.0		4.7	13.5	0.0			0.0		33.2	11.3		20.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.9	0.7	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.7	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
AC141272.1		ENSG00000277836			Unmapped	1270984-1271271	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 15.4;intestine: 16.4;lymphoid tissue: 22.4;urinary bladder: 14.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;K-562: 2.1;RH-30: 1.7;RPMI-8226: 5.9;SCLC-21H: 1.6"									"Group enriched"	"Detected in some"	113	"memory B-cell: 15.4;naive B-cell: 7.0"	"Lineage enriched"	"Detected in single"	155	"B-cells: 15.4"																																					0.0	0.0		6.5		1.5	1.0		0.0	2.9	16.2			16.4	0.0	0.0	1.3	0.0	0.0	0.0			0.0	0.0	0.0	3.2			0.0	0.0	0.0		0.0		0.0	5.2		10.9	0.0	0.0	0.0	8.3	0.0		4.3	11.6	0.0			0.0		22.4	14.5		15.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.9	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
AC136616.2		ENSG00000277761			Unmapped	1167457-1257196	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 17.8;intestine: 15.5;stomach 1: 13.5"	"Group enriched"	"Detected in some"	9	"HaCaT: 2.6;RH-30: 2.0;U-251 MG: 1.1;U-937: 2.6"									"Group enriched"	"Detected in some"	92	"memory B-cell: 17.8;naive B-cell: 4.7"	"Lineage enriched"	"Detected in single"	145	"B-cells: 17.8"																																					0.0	9.5		5.0		0.4	4.3		0.0	0.0	15.5			6.6	0.0	1.0	0.0	0.0	0.4	0.0			0.0	0.0	1.4	0.1			4.7	0.0	0.0		0.0		0.0	6.8		11.1	0.0	0.0	0.0	7.1	0.0		3.9	13.5	0.0			0.0		11.0	10.4		17.8	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6										
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 128.3;HUVEC TERT2: 107.9;TIME: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	5200000	5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.0	0.2	22.7	12.9	0.1	29.0	13.9	18.0	9.6	0.0	0.9	0.0	128.3	37.2	0.4	0.3	2.0	17.0	0.1	0.2	0.0	4.1	10.4	8.9	0.0	0.0	18.8	0.4	13.0	3.2	107.9	0.0	0.0	51.0	0.1	0.0	0.0	4.8	1.7	2.4	0.4	0.0	6.5	0.0	0.0	0.0	2.9	4.9	1.3	0.4	0.2	222.6	25.0	19.5	31.4	53.4	0.9	0.1	0.2	3.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981771-31991628	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in many"	4	"BEWO: 31.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	61	"memory B-cell: 9.1;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	71	"B-cells: 9.1"									HPA063386	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA063386: AB_2684999"	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	2.0	1.0	0.7	11.2	1.0	0.1	2.8	0.8	1.5	4.3	1.1	0.0	1.7	0.3	4.1	4.9	6.2	1.9	3.6	1.3	0.6	1.6	7.2	0.4	3.7	8.3	1.6	0.6	1.8	0.6	0.1	5.5	8.1	1.1	6.0	1.6	1.6	5.6	2.6	0.4	2.3	3.7	6.7	0.5	9.6	1.1	2.2	0.0	0.5	1.8	4.2	20.2	6.4	3.6	9.1	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.6	0.0	1.6	0.0	0.0	31.3	0.2	0.1	0.2	0.2	2.0	2.4	2.2	2.3	0.0	1.9	0.7	3.0	0.2	0.0	0.3	0.0	3.1	1.0	0.0	0.0	0.0	0.1	1.3	0.2	6.0	0.6	0.0	0.0	0.2	1.7	0.0	0.0	0.8	3.3	0.0	0.0	0.1	7.1	0.8	0.2	0.0	0.5	3.7	0.0	2.9	0.0	1.2	0.2	2.6	0.0	0.2	0.0	0.0	3.5	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.0	0.8	1.5	0.6	1.6	1.6	0.6	1.1	0.0
AC136616.3		ENSG00000278782			Unmapped	1157687-1240349	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.6;breast: 4.8;cervix, uterine: 6.8;intestine: 5.2;lymphoid tissue: 7.7"	"Cell line enriched"	"Detected in single"	16	"U-251 MG: 1.6"									"Cell type enriched"	"Detected in some"	6	"naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 6.6"																																					0.0	0.0		0.1		0.4	4.8		0.0	6.8	2.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.5		1.6	0.0	0.0	0.0	5.2	0.0		2.0	0.0	0.0			0.0		7.7	3.6		6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 45.1;lymphoid tissue: 44.6;skeletal muscle: 30.5"	"Group enriched"	"Detected in some"	8	"Karpas-707: 54.6;RPMI-8226: 34.3;U-266/70: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"memory B-cell: 45.1;naive B-cell: 13.1"	"Lineage enriched"	"Detected in single"	65	"B-cells: 45.1"					"Low region specificity"	"Detected in all"			HPA030453	Uncertain									"HPA030453: AB_10601700"	"unprognostic (3.94e-5)"	"unprognostic (1.11e-3)"	"unprognostic (4.88e-2)"	"unprognostic (4.30e-3)"		"unprognostic (1.23e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.61e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.59e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	0.5	0.3	0.4	17.6	0.3	0.2	0.5	0.2	0.3	0.7	3.0	0.1	0.0	1.9	0.3	0.0	2.7	0.5	0.5	2.5	0.3	0.3	0.6	0.5	1.2	12.5	0.3	0.2	0.3	0.3	0.0	0.3	0.0	0.1	0.9	1.2	0.6	9.0	1.1	30.5	0.3	14.8	0.0	0.4	44.6	2.4	0.3	0.1	0.9	0.6	0.9	37.8	2.3	0.4	45.1	0.0	0.1	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	13.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.9	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.1
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922023-41926818	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;intestine: 18.9;lymphoid tissue: 69.1"	"Group enriched"	"Detected in some"	6	"REH: 19.9;U-698: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	51	"memory B-cell: 14.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in single"	59	"B-cells: 20.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA003246, CAB008380"	Enhanced									"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.43e-4)"	"prognostic favourable (4.44e-7)"	"unprognostic (6.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.64e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-8)"	"unprognostic (2.21e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.44e-2)"	0.9	0.8	0.8	41.0	1.0	3.3	0.6	1.0	2.0	0.5	1.2	4.4	0.0	0.7	0.4	0.2	5.0	0.5	0.6	0.6	0.8	0.9	0.9	0.5	1.8	48.4	1.0	0.6	0.4	0.4	0.0	0.4	0.1	1.8	0.6	0.7	0.5	5.8	0.0	1.2	2.0	18.9	0.1	1.1	69.1	1.4	0.7	0.6	2.0	0.8	0.3	51.4	9.5	0.7	20.3	0.2	0.3	0.2	0.2	0.2	0.5	0.3	0.2	1.1	2.3	0.0	0.0	0.5	0.1	0.1	0.2	0.8	0.9	0.5	1.8	0.4	0.2	0.3	0.6	0.0	0.3	0.4	2.2	0.2	0.3	0.2	0.1	1.6	0.4	0.1	0.0	0.4	0.1	0.0	0.4	1.8	0.2	0.7	1.5	1.7	0.7	0.1	19.9	2.4	1.5	0.0	0.2	1.2	0.3	0.1	0.4	0.3	0.4	2.2	0.2	0.5	2.6	0.9	0.3	2.1	1.0	10.8	0.1	1.7	0.5	0.3	0.1	0.1	0.1	0.1	0.2	14.5	0.2	0.1	0.0	20.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.5	0.8	1.0	1.0	2.0	0.8	0.9	1.0	0.6	1.8	0.6
AC136428.1		ENSG00000259680			16	33844784-33845229	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.6;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	40	"B-cells: 4.0"																				"unprognostic (1.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.32e-2)"			"prognostic favourable (6.96e-5)"		"unprognostic (1.81e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"		"unprognostic (2.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.58e-1)"	0.6	0.4	0.4	5.0	0.4	1.8	1.6	0.4	0.4	2.7	7.0	0.5	0.2	5.9	0.5	0.2	2.3	1.1	0.2	1.1	0.4	0.4	0.9	0.5	2.0	0.2	0.4	0.2	0.4	0.4	0.0	0.4	0.2	0.2	0.5	3.7	0.5	3.4	0.2	0.4	0.4	5.7	0.2	0.4	6.8	6.9	0.5	0.2	0.2	0.5	0.2	15.7	6.3	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	0.2	0.2
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 18.1;Karpas-707: 16.1;U-698: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 14.7;naive B-cell: 15.9"	"Lineage enriched"	"Detected in single"	29	"B-cells: 15.9"	"Region enriched"	"Detected in many"	5	"thalamus: 56.1"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	27.5	2.2	7.3	10.6	7.3	2.3	10.0	2.4	7.1	8.3	5.8	10.1	4.8	4.8	7.8	14.1	9.6	8.9	8.1	5.9	7.7	6.7	4.5	5.1	12.1	13.5	10.5	3.0	4.7	2.8	8.2	5.1	13.9	11.1	4.1	6.2	3.4	3.5	5.4	6.4	8.9	6.0	5.7	19.6	28.9	4.5	7.3	7.7	39.7	6.0	5.8	13.3	7.4	8.5	15.9	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	12.2	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	6.8	3.0	4.8	4.7	0.0	1.7	18.1	1.6	0.0	7.6	2.0	0.3	0.9	0.0	0.0	0.0	1.3	0.8	4.6	0.0	0.1	7.5	0.0	16.1	0.0	0.2	1.5	0.0	0.9	0.5	0.8	0.0	0.0	3.6	8.0	0.3	0.1	0.0	2.1	1.5	0.0	0.0	7.6	0.0	1.7	0.0	3.3	0.0	0.0	11.2	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.5	14.7	0.3	0.4	0.0	15.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	7.3	7.3	2.4	7.1	7.7	6.7	10.5	3.0	11.1	7.7
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347355	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 68.2;REH: 20.2;U-698: 54.2;WM-115: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"memory B-cell: 29.8;naive B-cell: 39.3"	"Lineage enriched"	"Detected in many"	28	"B-cells: 39.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002418, HPA024353"	Enhanced									"CAB002418: AB_563529, HPA024353: AB_10600695"	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.1	1.0	5.5	57.9	6.8	3.1	0.5	0.7	3.2	1.4	1.0	0.9	0.5	0.4	1.4	0.9	4.4	7.9	2.9	0.8	9.9	4.2	1.4	0.6	5.5	52.6	9.8	0.5	35.4	0.5	0.0	0.7	1.0	0.9	2.8	1.5	1.1	5.9	1.1	0.5	0.0	11.6	2.0	13.5	64.1	1.4	1.2	0.6	5.0	1.1	2.3	77.8	4.3	0.9	39.3	1.3	0.3	0.3	0.0	0.0	1.4	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.2	68.2	1.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	20.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	54.2	0.5	0.2	12.4	0.0	0.0	0.0	0.0	0.3	0.0	29.8	0.0	0.0	1.3	39.3	0.0	0.0	0.3	0.0	0.2	1.1	0.0	1.4	5.5	6.8	0.7	3.2	9.9	4.2	9.8	0.5	0.9	0.6
EML6	FLJ42562	ENSG00000214595	"Echinoderm microtubule associated protein like 6"	Q6ZMW3	2	54723499-54972025	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;lymphoid tissue: 11.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;SCLC-21H: 20.1;U-698: 22.8"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.5"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062808, HPA068759"	Uncertain		Approved	Vesicles,Mitochondria				Mitochondria	Vesicles	"HPA062808: AB_2684872, HPA068759: AB_2686027"	"unprognostic (1.06e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.83e-2)"	"unprognostic (9.96e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.26e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.85e-6)"	"unprognostic (5.00e-1)"	"unprognostic (5.81e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.13e-3)"	0.1	3.3	1.8	4.0	2.8	0.0	0.2	7.2	4.2	0.0	0.6			0.6	0.0	1.3	0.3	0.4	0.1	0.0	1.9	2.1	1.3	0.2	0.1	7.9	1.5		0.0	0.5	3.0	3.4	1.4		0.4	0.8		0.1	0.4	0.6	0.8	1.8	0.3	0.5	2.7	0.4	1.5			3.1		11.9	0.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.1	0.7	0.2	1.5	0.1	0.2	0.2	0.2	0.6	0.2	7.2	0.1	0.4	0.2	1.0	0.3	0.3	0.7	0.3	0.4	0.5	2.7	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.0	1.1	0.0	0.7	1.4	0.2	0.3	1.1	0.6	0.5	0.6	0.0	0.7	20.1	2.7	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.6	0.4	0.4	4.9	1.2	22.8	1.2	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C12orf74		ENSG00000214215	"Chromosome 12 open reading frame 74"	Q32Q52	12	92702843-92708549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;RT4: 2.4;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"memory B-cell: 3.7;naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	21	"B-cells: 3.7"																				"unprognostic (2.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.28e-3)"	"unprognostic (4.55e-3)"		"unprognostic (7.95e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.57e-1)"		"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.83e-4)"	"unprognostic (3.03e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.42e-2)"	0.2	0.1	0.1	12.3	0.1	0.0	0.2	0.1	0.1	2.1	0.7	0.0	3.6	0.3	0.7	6.9	1.7	4.5	0.3	0.2	0.1	0.1	1.3	0.5	6.6	1.9	0.1	0.0	1.0	1.1	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.9	0.9	0.1	0.2	1.8	0.0	0.1	2.6	2.1	0.5	0.0	0.1	0.2	0.0	10.5	2.5	1.4	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	2.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552520	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.3;lymphoid tissue: 39.1;salivary gland: 12.4"	"Group enriched"	"Detected in some"	5	"U-266/70: 5.6;U-698: 12.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 11.4;naive B-cell: 13.3"	"Lineage enriched"	"Detected in single"	19	"B-cells: 13.3"														"Secreted to blood"	36000000	36000000				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.7	0.4	0.3	33.9	0.3	1.1	1.3	0.3	0.3	1.6	7.4	0.1	0.0	3.6	0.5	0.1	4.6	0.8	0.8	0.4	0.3	0.3	1.6	0.8	1.6	17.4	0.3	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.5	2.7	1.0	12.4	0.8	0.3	0.3	6.4	0.1	0.3	29.5	2.5	0.9	0.0	3.1	1.1	0.7	39.1	5.3	0.6	13.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32817048	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.1;lymphoid tissue: 33.0"	"Group enriched"	"Detected in some"	5	"Daudi: 32.7;U-698: 11.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 42.0;naive B-cell: 51.1"	"Lineage enriched"	"Detected in many"	19	"B-cells: 51.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013846	Enhanced									"HPA013846: AB_1853928"	"prognostic favourable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favourable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"	0.7	0.4	0.3	28.8	0.3	2.7	1.4	0.7	0.3	1.2	2.7	0.4	0.0	1.7	0.7	0.5	1.3	0.5	1.4	2.2	0.2	0.4	1.8	0.7	3.3	33.0	0.4	0.2	0.5	0.2	0.0	1.8	0.5	0.8	0.7	2.4	0.7	3.8	0.9	0.4	1.0	12.2	0.2	0.7	28.5	1.4	1.7	0.1	5.8	1.1	0.9	29.8	5.5	0.8	51.1	2.6	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	1.6	32.7	0.1	0.0	0.2	0.9	1.7	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.1	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.6	0.3	11.5	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	2.6	51.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	0.3	0.3	0.7	0.3	0.2	0.4	0.4	0.2	0.8	0.1
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 associating factor 1"	Q16633	11	111352252-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.2;lymphoid tissue: 84.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 45.4;Karpas-707: 52.0;U-266/70: 50.7;U-266/84: 22.8;U-698: 93.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"memory B-cell: 19.9;naive B-cell: 14.2"	"Lineage enriched"	"Detected in many"	13	"B-cells: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011193	Enhanced									"CAB011193: AB_532299"	"prognostic favourable (1.68e-4)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	0.9	0.5	0.6	62.7	0.7	2.0	1.4	0.4	0.6	1.9	7.8	1.8	0.0	6.7	0.7	0.3	8.7	1.1	1.4	0.5	0.8	0.7	2.1	1.0	2.6	42.6	1.0	0.5	1.2	0.5	0.0	0.4	0.5	1.2	1.3	4.1	1.2	8.4	0.9	0.4	0.4	21.2	0.0	1.4	74.2	12.2	1.0	0.9	5.0	1.7	1.4	84.0	5.0	1.4	19.9	0.1	1.5	0.2	0.3	0.7	0.6	0.1	0.1	0.0	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	45.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.7	52.0	0.0	0.1	0.2	0.2	0.0	0.0	9.7	0.1	12.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.4	0.0	0.0	50.7	22.8	93.3	0.0	0.1	0.0	1.5	0.1	0.3	0.1	0.1	0.1	19.9	0.2	0.1	0.0	14.2	0.2	0.1	0.9	0.3	0.2	0.1	0.7	0.6	0.6	0.7	0.4	0.6	0.8	0.7	1.0	0.5	1.2	0.9
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 77.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.6;hTERT-HME1: 9.5;RPTEC TERT1: 10.1;RT4: 29.4;U-266/70: 8.7;U-698: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 6.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 6.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.5	0.3	0.3	12.9	0.3	0.0	4.8	0.3	0.3	1.8	12.1	0.4	3.7	5.8	0.4	3.7	3.7	1.3	7.7	0.3	0.3	0.5	13.4	1.2	4.2	3.0	0.3	0.1	1.8	11.3	0.0	2.2	11.2	1.1	6.4	7.8	0.4	5.1	6.3	0.4	3.1	23.2	2.1	0.5	0.6	21.5	0.9	0.1	77.9	3.3	2.0	8.2	11.0	2.5	6.4	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	5.1	31.6	0.5	0.0	1.6	0.0	2.5	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	10.1	29.4	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	25.8	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	6.4	0.4	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.5	0.3	0.1	1.1	0.1
OR6V1	GPR138	ENSG00000225781	"Olfactory receptor family 6 subfamily V member 1"	Q8N148	7	143052320-143053347	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"					"Low region specificity"	"Detected in single"																							"unprognostic (3.24e-2)"								0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8			0.0		0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AIM2	PYHIN4	ENSG00000163568	"Absent in melanoma 2"	O14862	1	159062484-159147096	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 44.7;lymphoid tissue: 43.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.1;HDLM-2: 43.3;Karpas-707: 17.2;U-266/70: 14.5;U-266/84: 10.9;U-87 MG: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"memory B-cell: 44.7;naive B-cell: 14.3"	"Lineage enriched"	"Detected in many"	9	"B-cells: 44.7"	"Low region specificity"	"Detected in all"							"HPA031365, HPA040309"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Cytosol"	"HPA031365: AB_10601332, HPA040309: "	"unprognostic (6.05e-2)"	"unprognostic (7.68e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-12)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-3)"	0.7	0.3	1.3	28.2	0.9	0.4	0.6	0.5	0.6	0.4	1.9	0.1	0.0	0.7	0.2	0.2	4.1	0.5	1.1	0.5	1.2	0.6	0.9	0.8	2.0	24.1	0.5	0.2	0.6	0.3	0.0	8.8	0.4	0.5	0.7	1.0	0.5	1.9	0.0	0.2	0.3	12.8	0.2	2.6	43.8	1.3	1.4	1.4	1.4	0.7	0.6	25.9	4.0	0.5	44.7	1.2	4.7	2.4	0.0	3.3	1.4	5.2	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.5	0.4	0.3	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.3	43.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	2.8	0.0	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	14.5	10.9	0.2	13.4	1.1	2.2	4.2	2.4	0.0	0.6	2.1	1.7	44.7	1.6	1.1	1.2	14.3	0.1	0.4	4.7	0.0	2.2	0.0	3.3	1.4	1.3	0.9	0.5	0.6	1.2	0.6	0.5	0.2	0.5	1.4
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177225-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 27.0;Daudi: 53.1;U-698: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.3;naive B-cell: 7.6"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Enhanced	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: AB_2682897, HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"	3.0	9.0	6.4	22.2	8.1	1.5	5.9	2.6	5.3	5.0	5.9	4.0	3.4	4.6	5.4	7.4	4.7	7.2	6.6	3.2	5.6	5.6	9.0	4.5	5.1	22.4	4.6	2.7	8.3	14.6	12.7	10.6	4.3	3.8	5.1	7.2	3.4	5.7	5.9	1.1	1.7	7.3	3.8	4.5	9.9	5.1	10.5	3.2	13.6	10.2	3.0	26.0	6.0	7.6	13.3	1.4	0.0	0.0	1.1	0.6	0.6	4.8	5.2	27.0	10.0	0.5	0.7	8.7	0.9	2.1	0.8	2.3	3.1	5.7	53.1	3.8	1.1	1.0	15.7	1.3	1.0	5.5	7.2	5.3	2.9	7.3	4.3	1.6	0.0	1.0	2.1	1.0	3.8	0.8	11.2	0.4	1.4	3.1	5.4	3.5	8.7	4.6	4.3	1.1	5.7	8.7	3.4	3.3	10.4	0.6	1.8	8.0	11.3	1.7	0.0	1.3	1.0	1.5	3.5	10.0	6.7	25.4	1.5	1.3	2.6	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.1	7.6	0.2	0.4	0.0	1.1	0.0	1.4	0.6	0.6	6.4	8.1	2.6	4.5	5.6	5.6	4.6	2.7	3.8	3.2
CLEC20A	"FLJ44005, LINC00083, NCRNA00083, RP4-593C16.2"	ENSG00000188585	"C-type lectin domain containing 20A"		1	178479247-178499634	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 12.9;testis: 5.3"	"Cell line enriched"	"Detected in single"	5	"REH: 4.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory B-cell: 3.5;naive B-cell: 12.9"	"Lineage enriched"	"Detected in many"	8	"B-cells: 12.9"																																					0.0	0.0		0.4		2.1	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	2.9			0.0	0.0	0.0		0.0		0.3	0.0		0.0	0.1	0.0	0.0	0.0	0.0		1.0	0.5	5.3			0.0		1.9	0.0		12.9	0.5	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.3	12.9	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.2										
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;U-698: 18.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Low region specificity"	"Detected in all"			HPA028938	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028938: AB_10795352"	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.2	0.1	0.5	7.8	0.1	0.7	2.8	0.3	0.0	0.5	0.7	3.3	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.2	0.8	0.0	0.8	0.8	0.1	0.1	0.2	0.0	3.5	0.2	0.3	1.5	0.3	3.5	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	18.8	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4, X-linked"	Q8N0W4	X	5840637-6228863	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.3"	"Group enriched"	"Detected in some"	4	"AF22: 30.9;NTERA-2: 24.4"	"Cancer enhanced"	"Detected in many"		"glioma: 8.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	6	"B-cells: 1.5"									HPA001651	Approved									"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	4.9	2.3	8.3	2.8	10.7	0.3	3.4	12.2	19.2	8.2	3.6	3.7	0.4	2.1	3.7	1.0	1.3	3.4	4.0	5.4	7.9	9.9	0.8	2.2	1.9	1.7	5.6	6.4	16.8	0.9	12.3	2.6	5.4	5.7	2.0	3.2	2.1	1.5	3.3	0.7	1.2	2.9	5.6	4.3	3.2	1.9	3.9	3.9	56.3	1.0	0.0	1.1	3.6	1.8	1.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	3.9	0.0	24.4	0.0	0.0	0.0	0.0	2.2	6.2	1.5	1.9	0.0	0.0	0.0	3.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.3	10.7	12.2	14.7	7.9	9.9	5.6	6.4	5.7	3.9
GRAPL		ENSG00000189152	"GRB2 related adaptor protein like"	Q8TC17	17	19127469-19159176	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	7	"Daudi: 21.7;HUVEC TERT2: 9.0;TIME: 24.0;U-698: 20.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 10.8"	"Lineage enriched"	"Detected in many"	5	"B-cells: 10.8"									"HPA051796, HPA066654"	Uncertain		Approved	Centrosome				Centrosome		"HPA051796: AB_2681613, HPA066654: AB_2685699"	"unprognostic (2.85e-1)"		"unprognostic (3.37e-1)"		"unprognostic (5.09e-4)"	"unprognostic (4.49e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	4.6	1.6	0.7	9.5	1.7	1.0	1.7	0.4	2.0	1.5	1.3	0.1	2.9	0.7	3.6	1.9	2.5	1.6	2.2	3.4	1.7	0.8	2.8	1.8	4.6	15.6	1.1	1.2	1.1	0.4	0.0	1.0	1.7	1.0	1.4	1.3	1.0	1.4	1.3	2.3	0.7	9.7	1.9	0.9	20.6	0.8	1.1	0.5	7.7	2.7	1.7	17.0	1.7	2.3	10.8	0.1	0.0	0.0	0.0	2.2	0.7	0.0	1.2	1.5	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.3	21.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	2.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	24.0	0.0	0.2	1.1	0.0	0.0	0.0	20.1	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	10.8	1.4	0.3	0.1	4.1	2.2	0.7	0.0	0.0	0.0	0.0	0.9	0.7	0.7	1.7	0.4	2.0	1.7	0.8	1.1	1.2	1.0	0.5
SEMA3D	"coll-2, Sema-Z2"	ENSG00000153993	"Semaphorin 3D"	O95025	7	84995553-85186855	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.8;thyroid gland: 33.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.8;HaCaT: 17.1;TIME: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"amygdala: 17.1"	"Cell type enriched"	"Detected in single"	5	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037522	Uncertain		Approved	"Golgi apparatus,Plasma membrane"	"Secreted in other tissues"	77000	77000	"Golgi apparatus"	"Plasma membrane"	"HPA037522: AB_10672494"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.58e-3)"	"unprognostic (4.02e-3)"	"unprognostic (9.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.25e-3)"	4.1	2.2	17.1	1.9	2.3	0.1	4.3	0.8	2.8	4.6	2.9	1.8	2.5	1.4	1.9	7.4	1.3	3.9	1.4	2.0	3.6	2.7	3.0	1.0	3.6	6.1	2.4	3.1	4.1	0.8	0.4	1.5	0.6	5.4	6.2	2.6	2.6	5.6	2.9	0.7	2.1	2.7	3.2	4.8	33.8	2.4	4.3	2.5	0.0	33.0	0.6	1.1	4.7	3.9	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	4.5	4.9	5.4	2.6	0.0	0.0	0.0	1.4	16.8	17.1	1.9	0.0	3.6	0.0	3.5	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	4.4	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.5	1.2	5.4	3.9	1.7	0.0	0.1	0.6	0.0	0.0	0.2	0.2	0.0	26.2	0.0	1.7	0.2	0.0	3.3	1.9	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.1	2.3	0.8	2.2	3.6	2.7	2.4	3.1	5.4	2.5
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in some"	6	"Daudi: 51.5;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	51.5	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.1	0.0	2.0	4.5	0.0	0.1	1.0	0.0	0.5	0.4	7.0	1.3	0.9	0.0	0.1	1.7	4.8	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.4	0.1	30.2	0.2	0.5	0.3	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9
